Structural characterization of anti-inflammatory immunoglobulin G Fc proteins
Copyright © 2014 Elsevier Ltd. All rights reserved..
Immunoglobulin G (IgG) is a central mediator of host defense due to its ability to recognize and eliminate pathogens. The recognition and effector responses are encoded on distinct regions of IgGs. The diversity of the antigen recognition Fab domains accounts for IgG's ability to bind with high specificity to essentially any antigen. Recent studies have indicated that the Fc effector domain also displays considerable heterogeneity, accounting for its complex effector functions of inflammation, modulation, and immune suppression. Therapeutic anti-tumor antibodies, for example, require the pro-inflammatory properties of the IgG Fc to eliminate tumor cells, while the anti-inflammatory activity of intravenous IgG requires specific Fc glycans for activity. In particular, the anti-inflammatory activity of intravenous IgG is ascribed to a small population of IgGs in which the Asn297-linked complex N-glycans attached to each Fc CH2 domain include terminal α2,6-linked sialic acids. We used chemoenzymatic glycoengineering to prepare fully disialylated IgG Fc and solved its crystal structure. Comparison of the structures of asialylated Fc, sialylated Fc, and F241A Fc, a mutant that displays increased glycan sialylation, suggests that increased conformational flexibility of the CH2 domain is associated with the switch from pro-inflammatory to anti-inflammatory activity of the Fc.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:426 |
---|---|
Enthalten in: |
Journal of molecular biology - 426(2014), 18 vom: 09. Sept., Seite 3166-3179 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ahmed, Alysia A [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.12.2014 Date Revised 21.10.2021 published: Print-Electronic PDB: 4Q6Y, 4Q74, 4Q7D Citation Status MEDLINE |
---|
doi: |
10.1016/j.jmb.2014.07.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM240177754 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM240177754 | ||
003 | DE-627 | ||
005 | 20231224121540.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jmb.2014.07.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n0800.xml |
035 | |a (DE-627)NLM240177754 | ||
035 | |a (NLM)25036289 | ||
035 | |a (PII)S0022-2836(14)00340-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ahmed, Alysia A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Structural characterization of anti-inflammatory immunoglobulin G Fc proteins |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.12.2014 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a PDB: 4Q6Y, 4Q74, 4Q7D | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2014 Elsevier Ltd. All rights reserved. | ||
520 | |a Immunoglobulin G (IgG) is a central mediator of host defense due to its ability to recognize and eliminate pathogens. The recognition and effector responses are encoded on distinct regions of IgGs. The diversity of the antigen recognition Fab domains accounts for IgG's ability to bind with high specificity to essentially any antigen. Recent studies have indicated that the Fc effector domain also displays considerable heterogeneity, accounting for its complex effector functions of inflammation, modulation, and immune suppression. Therapeutic anti-tumor antibodies, for example, require the pro-inflammatory properties of the IgG Fc to eliminate tumor cells, while the anti-inflammatory activity of intravenous IgG requires specific Fc glycans for activity. In particular, the anti-inflammatory activity of intravenous IgG is ascribed to a small population of IgGs in which the Asn297-linked complex N-glycans attached to each Fc CH2 domain include terminal α2,6-linked sialic acids. We used chemoenzymatic glycoengineering to prepare fully disialylated IgG Fc and solved its crystal structure. Comparison of the structures of asialylated Fc, sialylated Fc, and F241A Fc, a mutant that displays increased glycan sialylation, suggests that increased conformational flexibility of the CH2 domain is associated with the switch from pro-inflammatory to anti-inflammatory activity of the Fc | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a IVIG | |
650 | 4 | |a N-linked glycan | |
650 | 4 | |a X-ray crystallography | |
650 | 4 | |a inflammation | |
650 | 4 | |a sialylated IgG Fc | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Antigens |2 NLM | |
650 | 7 | |a Immunoglobulin Fc Fragments |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Immunoglobulins, Intravenous |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
650 | 7 | |a Sialic Acids |2 NLM | |
700 | 1 | |a Giddens, John |e verfasserin |4 aut | |
700 | 1 | |a Pincetic, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Lomino, Joseph V |e verfasserin |4 aut | |
700 | 1 | |a Ravetch, Jeffrey V |e verfasserin |4 aut | |
700 | 1 | |a Wang, Lai-Xi |e verfasserin |4 aut | |
700 | 1 | |a Bjorkman, Pamela J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of molecular biology |d 1960 |g 426(2014), 18 vom: 09. Sept., Seite 3166-3179 |w (DE-627)NLM000006777 |x 1089-8638 |7 nnns |
773 | 1 | 8 | |g volume:426 |g year:2014 |g number:18 |g day:09 |g month:09 |g pages:3166-3179 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jmb.2014.07.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 426 |j 2014 |e 18 |b 09 |c 09 |h 3166-3179 |